David Krantz and I talk about how our unique genetics influence our metabolism of cannabis (nutrigenomics) and the resulting impact of cannabis use on our epigenetic health. Furthermore, we reach into a discussion on how the same framework of understanding applies to our metabolism of psychedelics and the potential future of a genome-specific screening program for psychedelic-assisted psychotherapy.
Hamilton Souther joins us on the podcast to talks about what it takes to become a true shaman, the medicine of the plants, and what the new age culture gets wrong about ayahuasca.
Amanda Siebert and I sit down to talk about what the science says about the pharmacology of the plant’s various components as well as the anecdotal uses of cannabis for bettering different areas of our lives, from sex to death. Of course, we also talk about the negatives, from cannabis addiction to cannabis hyperemesis syndrome.
R. Coleman takes us through the wealth of knowledge he has earned over his 30 years of healing trauma with psychedelic psychotherapy. We discuss trauma in general, the value of psychedelic to heal it, and the nuances of working with different psychedelics, for different people, at different times, for different issues.





